Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
ADCY4	AC4	ENSG00000129467	"Adenylate cyclase 4"	Q8NFM4	14	24318349-24335093	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"cAMP biosynthesis"	Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Adipocytes: 90.9;Endothelial cells: 74.6;Hepatic stellate cells: 50.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	9	"basophil: 2.9"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 2.9"	"Group enriched"	"Detected in some"	6	"HUVEC TERT2: 2.9;TIME: 5.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB005070, HPA048344"	Approved					NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"CAB005070: AB_2273639, HPA048344: AB_2680366"	"unprognostic (5.59e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.47e-4)"	"prognostic favorable (8.20e-4)"	"unprognostic (4.06e-1)"	"unprognostic (2.82e-3)"	"unprognostic (1.75e-4)"	"unprognostic (8.58e-2)"	"unprognostic (2.51e-2)"	"unprognostic (7.88e-2)"	"unprognostic (6.77e-2)"	"unprognostic (7.87e-2)"	"prognostic unfavorable (7.01e-4)"	"unprognostic (8.02e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.47e-2)"	18.0	2.6	2.8	2.3	2.2	0.0	16.1	2.2	2.8	9.2	2.0	3.9	0.9	8.8	0.5	3.7	8.2	2.9	16.9	2.0	2.1	10.2	1.4	9.9	1.6	2.7	2.5	2.4	2.3	1.0	1.7	9.9	2.6	5.3	0.7	0.0	3.7	1.4	4.3	4.7	4.5	1.9	2.4	9.9	3.7	1.1	3.0	0.4	7.7	2.8	0.8	5.9	6.7	2.3	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.3	0.0	0.3	0.2	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.1	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	5.1	0.1	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	2.8	2.2	2.2	2.8	2.0	2.1	2.7	2.5	2.6	2.4	3.0	2.3	90.9	0.0	1.8	0.3	1.0	3.6	0.4	0.3	3.4	0.0	1.5	1.5	10.6	0.0	0.9	1.8	0.0	0.2	1.6	2.9	0.0	1.2	1.3	0.5	1.1	74.6	1.2	0.4	0.2	3.1	0.1	4.7	7.1	0.6	1.3	0.0	50.3	0.2	1.4	1.7	0.2	7.9	0.0	5.0	3.1	6.9	0.0	1.5	7.2	12.2	2.5	0.9	1.0	0.0	0.0	2.1	3.8	0.0	1.4	0.4	2.4	0.0	1.1	0.2	6.6	1.7	5.7	0.3	0.8	0.6	2.8	0.0	1.6	0.5	2.1	0.2
ADGRF5	"DKFZp564O1923, GPR116, KIAA0758"	ENSG00000069122	"Adhesion G protein-coupled receptor F5"	Q8IZF2	6	46852522-46954943	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 104.5"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 428.1;Alveolar cells type 1: 291.7;Alveolar cells type 2: 539.9;Endothelial cells: 222.6;Hepatic stellate cells: 251.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"HUVEC TERT2: 25.0;TIME: 74.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA		55000000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"				"unprognostic (8.45e-2)"	"unprognostic (3.00e-3)"	"unprognostic (1.13e-1)"	"unprognostic (3.26e-1)"	"unprognostic (6.51e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.76e-2)"	"unprognostic (9.00e-3)"	"unprognostic (7.80e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.56e-2)"	"prognostic favorable (8.84e-5)"	"unprognostic (1.43e-2)"	"unprognostic (5.91e-2)"	"unprognostic (2.82e-2)"	"unprognostic (3.78e-2)"	69.8	22.8	15.1	6.9	15.0	0.0	46.0	15.0	18.0	10.4	8.6	9.9	5.7	16.0	7.7	7.0	15.0	16.9	51.6	12.8	15.1	58.9	13.0	104.5	8.5	16.6	15.6	6.5	6.4	13.2	6.7	50.6	18.2	8.9	5.7	1.8	5.9	9.2	30.4	7.7	8.5	21.8	13.8	40.5	8.4	3.1	21.6	3.7	32.2	70.2	3.2	11.4	10.0	15.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	74.1	0.0	0.2	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.1	15.0	15.0	18.0	12.8	15.1	16.6	15.6	18.2	13.8	21.6	15.3	428.1	291.7	539.9	2.0	2.9	0.0	0.2	0.0	2.2	0.0	1.5	2.9	16.2	8.6	89.7	1.8	0.0	0.2	1.1	0.6	11.7	0.2	10.6	0.8	1.2	222.6	0.0	0.0	8.4	0.0	1.1	9.0	2.6	0.4	12.6	0.0	251.3	4.0	0.2	0.0	1.0	0.5	0.0	13.7	0.0	4.8	3.1	2.7	0.0	104.0	0.0	0.0	0.0	1.0	0.4	0.0	0.0	0.0	1.2	0.6	0.5	0.2	48.1	0.7	98.6	9.6	80.1	0.2	0.9	0.6	0.0	0.3	1.8	15.5	0.1	0.8
ADGRL4	"ELTD1, ETL"	ENSG00000162618	"Adhesion G protein-coupled receptor L4"	Q9HBW9	1	78889764-79282124	"G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 73.1"	"Group enriched"	"Detected in many"	5	"Adipocytes: 559.9;Endothelial cells: 276.0;Hepatic stellate cells: 287.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"hTERT-RPE1: 101.2;HUVEC TERT2: 330.0;TIME: 379.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA025229	Supported					NA	NA		3800000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA025229: AB_10602493"	"unprognostic (2.67e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.58e-1)"	"unprognostic (5.32e-2)"	"unprognostic (8.11e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.23e-1)"	"unprognostic (7.52e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (1.60e-4)"	"unprognostic (5.32e-3)"	"unprognostic (1.48e-1)"	"unprognostic (3.45e-2)"	"unprognostic (3.85e-3)"	73.1	8.2	7.7	9.7	8.2	0.7	64.0	8.5	13.8	22.1	7.0	9.3	4.7	16.3	6.2	9.0	12.1	22.4	24.2	8.0	8.0	15.2	14.3	18.0	9.9	9.1	7.7	4.8	4.7	9.7	5.1	22.5	9.1	9.4	6.3	3.0	7.9	8.9	14.2	9.0	8.6	27.6	7.6	39.8	8.0	6.7	9.8	4.6	20.8	23.6	7.1	24.0	10.4	8.4	0.0	0.0	25.7	0.2	7.3	24.7	0.0	7.8	7.7	0.5	0.3	0.8	0.2	0.2	0.6	22.5	0.0	0.0	0.1	0.0	5.0	0.0	0.0	0.5	0.7	0.1	25.3	0.0	0.3	17.8	0.4	55.7	0.3	101.2	330.0	0.2	0.4	2.5	7.0	0.0	0.0	1.0	0.4	0.2	0.4	0.2	0.0	0.0	61.1	3.1	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	379.3	0.2	5.8	2.0	0.0	0.8	0.5	0.1	0.3	0.5	26.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	7.7	8.2	8.5	13.8	8.0	8.0	9.1	7.7	9.1	7.6	9.8	8.4	559.9	0.0	6.0	0.3	1.2	0.0	0.4	0.0	4.6	0.0	1.8	2.5	7.6	5.7	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.2	45.3	0.8	1.5	276.0	0.0	2.7	1.5	0.2	0.0	10.2	0.0	3.8	0.0	0.0	287.7	3.5	0.6	1.7	1.0	0.0	0.0	19.2	0.0	57.9	0.6	1.5	0.0	72.1	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.4	1.2	1.3	0.0	0.0	0.0	0.4	0.0	5.1	5.7	7.2	1.8	1.0	0.0	0.0	1.1	5.4	0.0	0.7
CD93	"C1qR(P), C1QR1, C1qRP, CDw93, dJ737E23.1, ECSM3, MXRA4"	ENSG00000125810	"CD93 molecule"	Q9NPY3	20	23079360-23086324	"CD markers, Plasma proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 137.6"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 321.5;Endothelial cells: 309.2;Hepatic stellate cells: 162.8;Kupffer cells: 156.4;Macrophages: 102.4;monocytes: 131.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	15	"classical monocyte: 25.8;intermediate monocyte: 16.8;myeloid DC: 9.1;neutrophil: 27.8;non-classical monocyte: 7.5"	"Group enriched"	"Detected in many"	41	"dendritic cells: 9.1;granulocytes: 27.8;monocytes: 25.8"	"Group enriched"	"Detected in some"	4	"HUVEC TERT2: 346.0;TIME: 442.2;U-937: 593.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009300, HPA012368"	Enhanced		Approved	"Vesicles,Plasma membrane"		NA	NA		550000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 32: U-937 - Innate immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Vesicles, Plasma membrane"		"HPA009300: AB_1846342, HPA012368: AB_1846341"	"unprognostic (2.05e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.83e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.66e-2)"	"unprognostic (6.45e-2)"	"unprognostic (2.77e-1)"	"unprognostic (4.51e-1)"	"unprognostic (3.74e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (2.74e-4)"	"unprognostic (8.81e-3)"	"unprognostic (6.13e-2)"	"unprognostic (4.49e-2)"	"unprognostic (3.11e-2)"	81.4	11.9	2.7	43.5	2.6	16.4	41.0	2.8	6.5	23.9	6.5	13.8	9.8	17.8	6.1	19.0	23.4	39.7	34.3	2.7	3.5	25.6	16.3	64.6	14.0	5.4	4.3	6.2	13.2	10.8	6.6	137.6	5.4	11.3	12.1	1.4	9.7	10.9	24.2	12.2	14.5	43.5	4.0	23.4	13.0	4.6	7.1	9.3	21.4	34.4	10.6	41.3	12.8	3.5	0.2	0.0	4.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	346.0	0.0	0.9	0.0	0.0	0.0	0.0	13.1	0.0	0.0	0.0	0.9	0.2	27.8	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.0	0.0	105.3	442.2	0.0	0.1	0.1	0.5	0.0	0.0	0.3	0.0	593.5	0.1	0.0	25.8	0.4	0.3	16.8	0.0	0.0	0.2	0.1	9.1	0.0	0.0	0.0	27.8	0.1	7.5	1.2	0.5	9.9	2.7	2.6	2.8	6.5	2.7	3.5	5.4	4.3	5.4	4.0	7.1	3.5	321.5	3.2	7.4	0.0	2.4	15.0	1.0	0.0	6.2	0.0	1.0	1.8	14.3	5.7	3.7	0.0	0.0	0.2	5.0	0.0	0.0	0.5	0.4	0.4	0.7	309.2	0.0	1.3	0.0	0.0	0.5	9.8	0.5	0.4	5.1	0.0	162.8	1.9	19.9	0.0	0.2	0.0	0.0	156.4	52.5	0.8	1.8	102.4	8.8	4.7	131.8	0.2	6.2	0.0	0.1	0.1	0.0	27.8	2.1	4.1	0.0	0.3	3.0	0.1	19.7	5.7	8.0	0.0	0.2	1.6	10.1	0.4	2.4	3.0	0.0	4.0
CDH5	"7B4, CD144"	ENSG00000179776	"Cadherin 5"	P33151	16	66366622-66404784	"Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 235.9"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 311.9;Endothelial cells: 206.1;Hepatic stellate cells: 185.6;Late spermatids: 84.6;Syncytiotrophoblasts: 80.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HUVEC TERT2: 752.5;TIME: 655.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB028366, HPA075875"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Plasma membrane"		NA	NA		1300000000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"	"Nucleoplasm, Nuclear membrane"	"CAB028366: AB_2276033, HPA075875: "	"unprognostic (1.05e-1)"	"unprognostic (8.13e-2)"	"unprognostic (6.11e-2)"	"unprognostic (4.89e-2)"	"unprognostic (4.96e-2)"	"unprognostic (5.50e-3)"	"unprognostic (9.38e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.33e-2)"	"unprognostic (2.32e-1)"	"prognostic unfavorable (5.14e-4)"	"unprognostic (9.49e-3)"	"unprognostic (3.01e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.15e-2)"	84.5	13.8	16.3	14.9	15.9	0.2	71.4	15.1	16.6	16.2	11.3	16.8	7.9	19.9	8.6	12.4	17.1	29.7	84.4	13.8	14.6	19.1	24.0	95.0	13.1	16.7	16.6	8.1	7.7	10.3	7.4	235.9	17.9	11.6	10.2	1.3	12.0	9.1	41.8	16.7	17.0	27.8	15.5	20.4	13.3	10.5	22.6	5.2	37.5	58.9	7.9	22.1	14.2	15.5	0.5	0.6	4.6	0.0	0.0	0.0	47.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	119.8	0.0	0.0	0.7	0.0	0.0	0.0	0.3	0.0	1.0	0.0	0.3	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	752.5	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.1	0.1	0.0	15.7	0.0	2.4	0.0	0.1	655.1	0.0	0.9	0.1	0.0	0.0	0.2	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	16.3	15.9	15.1	16.6	13.8	14.6	16.7	16.6	17.9	15.5	22.6	15.5	311.9	0.0	6.2	1.3	0.7	4.1	0.0	0.0	1.8	0.0	1.0	2.7	17.9	5.7	0.6	1.8	0.0	6.6	0.5	0.0	0.0	0.2	33.5	0.5	0.6	206.1	0.0	10.7	0.1	0.0	48.9	7.1	0.0	1.3	3.8	0.0	185.6	1.7	2.3	0.0	0.1	0.0	0.0	35.7	6.3	84.6	6.2	1.2	12.4	28.1	0.1	0.3	0.0	0.5	0.1	0.0	0.0	2.6	2.5	0.1	0.0	0.0	0.0	0.0	0.0	5.0	5.4	10.9	0.3	0.3	3.0	80.7	1.5	3.0	0.1	0.2
CLEC14A	C14orf27	ENSG00000176435	"C-type lectin domain containing 14A"	Q86T13	14	38254000-38256093	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	13	"Adipocytes: 396.6;Endothelial cells: 272.8;Hepatic stellate cells: 567.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 83.7;HUVEC TERT2: 451.8;TIME: 158.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039468, HPA048119"	Uncertain		Supported	"Endoplasmic reticulum,Golgi apparatus"		NA	NA		4100000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Endoplasmic reticulum, Golgi apparatus"		"HPA039468: AB_2676524, HPA048119: AB_2680270"	"unprognostic (4.02e-1)"	"unprognostic (4.26e-2)"	"unprognostic (4.20e-3)"	"unprognostic (9.44e-2)"	"unprognostic (1.35e-1)"	"prognostic favorable (4.13e-6)"	"unprognostic (2.55e-3)"	"unprognostic (2.69e-1)"	"unprognostic (1.67e-1)"	"unprognostic (6.90e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.97e-2)"	"unprognostic (5.28e-2)"	67.1	9.5	13.6	7.9	13.4	0.1	50.6	13.8	15.2	24.8	10.9	15.2	10.1	31.2	7.6	11.1	22.6	19.0	65.1	11.5	13.3	15.9	9.4	55.5	6.6	15.0	13.9	9.5	7.8	10.5	6.1	25.0	15.4	14.5	7.2	0.8	13.6	9.8	33.2	15.8	18.8	19.8	13.1	16.7	13.8	3.5	14.9	4.6	31.4	43.3	4.2	19.2	16.8	15.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	83.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	451.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	158.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.6	13.4	13.8	15.2	11.5	13.3	15.0	13.9	15.4	13.1	14.9	15.6	396.6	0.0	3.2	0.0	0.9	3.4	0.2	0.0	1.8	0.1	1.5	2.5	6.4	1.5	0.6	0.0	0.0	0.1	0.2	0.0	0.0	0.1	1.1	0.2	0.5	272.8	0.0	0.0	0.4	0.2	0.1	31.0	0.0	0.3	1.3	0.1	567.2	2.1	0.4	0.0	0.2	0.0	0.0	6.4	3.1	1.0	0.6	1.1	5.4	15.0	0.0	0.2	0.0	4.0	2.9	0.0	0.0	0.4	1.4	0.2	0.0	0.0	0.0	0.5	0.0	14.1	7.5	1.6	0.9	0.9	3.1	0.1	1.3	6.7	0.0	0.3
CYYR1	C21orf95	ENSG00000166265	"Cysteine and tyrosine rich 1"	Q96J86	21	26466209-26573286	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Adipocytes: 200.0;Endothelial cells: 150.0;Hepatic stellate cells: 79.9;Microglial cells: 58.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	38	"plasmacytoid DC: 31.4"	"Lineage enriched"	"Detected in single"	82	"dendritic cells: 31.4"	"Cell line enhanced"	"Detected in some"		"AF22: 14.1;NTERA-2: 39.2;PC-3: 11.0;RH-30: 16.6;SCLC-21H: 33.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034921, HPA067685"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"CAB034921: AB_2089315, HPA067685: AB_2685887"	"unprognostic (5.64e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.88e-1)"	"unprognostic (7.00e-2)"	"unprognostic (2.63e-2)"	"unprognostic (2.88e-3)"	"unprognostic (4.04e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.44e-3)"	"unprognostic (9.29e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.49e-2)"	36.4	46.4	9.7	8.1	9.0	7.8	30.2	8.7	11.4	16.4	8.4	8.4	6.1	19.2	8.1	9.0	12.9	16.1	22.3	8.1	9.4	12.7	4.8	23.7	6.0	9.9	10.5	4.5	5.5	15.5	3.8	36.3	10.6	9.5	6.6	0.9	6.8	11.4	15.1	8.2	9.6	23.6	9.6	32.5	7.7	1.9	10.8	6.0	14.1	31.8	4.6	12.6	9.5	9.4	0.0	0.0	14.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	7.1	1.6	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	6.5	0.0	0.4	0.0	5.6	0.0	0.0	0.0	2.6	0.0	0.0	0.1	39.2	0.0	11.0	0.0	16.6	0.0	1.7	0.0	33.7	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	3.9	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.3	0.0	0.0	31.4	0.0	0.1	9.7	9.0	8.7	11.4	8.1	9.4	9.9	10.5	10.6	9.6	10.8	9.4	200.0	0.0	0.6	1.6	1.5	11.7	2.0	10.2	27.3	0.1	14.9	15.0	6.7	0.0	1.7	14.7	0.0	0.1	14.9	0.0	3.9	0.0	0.7	0.4	6.9	150.0	0.0	11.1	1.6	0.0	0.2	8.3	0.0	0.4	0.0	3.7	79.9	0.4	0.3	0.0	4.6	0.0	2.0	3.2	8.0	1.5	2.1	1.4	7.2	58.1	0.7	0.5	0.0	0.0	0.7	0.1	0.0	0.0	2.5	1.1	0.0	6.8	1.1	0.3	0.0	13.3	4.4	0.2	1.3	4.9	5.4	0.3	1.5	0.4	0.0	0.7
DIPK2B	"CXorf36, DIA1R, FLJ14103"	ENSG00000147113	"Divergent protein kinase domain 2B"	Q9H7Y0	X	45148373-45200901	"Disease related genes, Predicted secreted proteins"			"Autism, Autism spectrum disorder"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	4	"Adipocytes: 96.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	57	"HUVEC TERT2: 81.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA002806	Uncertain				"Secreted - unknown location"	NA	NA		940000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 43: Cardiomyocytes - Nuclear processes"			"HPA002806: AB_1078595"	"unprognostic (2.12e-1)"	"unprognostic (1.32e-2)"	"unprognostic (8.51e-3)"	"unprognostic (2.05e-1)"	"unprognostic (4.65e-2)"	"unprognostic (4.07e-3)"	"unprognostic (7.30e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.39e-1)"	"unprognostic (6.06e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.75e-3)"	"unprognostic (3.79e-3)"	"unprognostic (1.98e-1)"	"unprognostic (8.47e-2)"	"unprognostic (3.11e-2)"	40.8	5.3	14.4	6.1	15.0	0.8	36.9	11.7	13.9	19.6	7.8	9.1	2.6	20.5	6.9	6.5	18.0	8.8	27.3	11.4	13.1	7.0	1.4	14.1	5.7	14.4	14.2	6.9	3.5	4.6	3.3	40.5	14.1	11.3	3.8	1.4	6.8	7.2	16.6	7.4	7.7	20.7	12.4	3.1	6.3	1.5	14.8	2.7	18.5	16.6	3.4	14.3	13.9	15.4	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.3	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.1	81.7	0.1	0.0	0.5	0.0	0.1	0.0	0.3	0.1	1.4	0.5	0.1	0.1	0.1	0.1	0.1	0.3	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.5	0.1	0.1	0.0	0.0	0.3	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	14.4	15.0	11.7	13.9	11.4	13.1	14.4	14.2	14.1	12.4	14.8	15.4	96.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	23.3	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0
ERG	"erg-3, p55"	ENSG00000157554	"ETS transcription factor ERG"	P11308	21	38380027-38661780	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 94.4;Endothelial cells: 105.5;Hepatic stellate cells: 69.9;Microglial cells: 88.1"	"Cancer enriched"	"Detected in all"	4	"prostate cancer: 18.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HUVEC TERT2: 138.3;MOLT-4: 47.7;REH: 151.5;TIME: 113.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018377, HPA046598"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	Cytosol	"CAB018377: AB_675518, HPA046598: AB_2679715"	"unprognostic (2.14e-1)"	"prognostic unfavorable (6.18e-6)"	"unprognostic (6.44e-3)"	"unprognostic (8.64e-3)"	"unprognostic (5.65e-2)"	"unprognostic (1.91e-1)"	"unprognostic (9.03e-4)"	"unprognostic (4.30e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.42e-2)"	"unprognostic (2.89e-1)"	"prognostic unfavorable (3.94e-4)"	"unprognostic (4.31e-3)"	"unprognostic (3.88e-2)"	"unprognostic (2.64e-2)"	"unprognostic (5.63e-3)"	24.6	4.1	5.1	7.1	5.5	7.6	20.0	5.0	5.5	10.0	3.0	5.4	3.4	11.6	1.9	5.2	9.1	12.0	12.4	4.5	5.1	12.8	6.1	19.6	7.5	5.9	5.4	4.4	4.9	2.4	2.4	24.3	6.2	7.1	3.4	0.5	3.7	4.3	7.9	4.9	6.5	12.0	4.7	26.6	4.6	1.5	7.0	4.1	10.0	9.9	3.7	9.2	6.9	5.4	0.0	0.0	1.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.6	0.0	0.0	0.2	22.3	0.0	0.1	0.9	0.0	0.0	138.3	0.1	0.0	0.0	0.0	1.0	47.7	0.0	0.5	0.0	0.0	151.5	0.0	0.0	0.0	0.1	0.1	0.0	1.1	0.2	0.0	0.0	0.0	0.0	113.4	0.7	2.2	0.5	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.1	5.5	5.0	5.5	4.5	5.1	5.9	5.4	6.2	4.7	7.0	5.4	94.4	0.0	3.9	0.3	0.7	3.4	1.7	0.6	3.4	0.0	0.6	4.3	3.8	4.3	1.3	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.7	0.7	0.4	105.5	0.0	13.5	13.3	0.0	0.0	5.7	0.0	2.1	24.0	4.4	69.9	1.3	0.3	0.0	1.7	0.4	0.0	5.9	3.4	2.1	0.9	0.9	3.6	88.1	0.2	0.0	0.0	7.1	1.4	0.0	0.0	0.0	1.5	1.4	0.0	0.0	0.0	0.1	0.0	2.4	3.7	0.3	1.4	0.5	3.4	0.0	0.6	0.5	0.3	0.6
ESAM	W117m	ENSG00000149564	"Endothelial cell adhesion molecule"	Q96AP7	11	124752583-124762290	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 405.9;Endothelial cells: 301.0;Hepatic stellate cells: 138.1;Sertoli cells: 151.2;Smooth muscle cells: 89.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 8.2;naive B-cell: 7.5"	"Group enriched"	"Detected in many"	9	"B-cells: 7.5;granulocytes: 8.2;T-cells: 2.2"	"Group enriched"	"Detected in many"	10	"HEL: 218.8;HUVEC TERT2: 277.9;TIME: 142.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056293, HPA072563"	Uncertain		Approved	"Cell Junctions,Cytosol"		NA	NA		82000000	"Cluster 34: Basophils - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Cell Junctions"	Cytosol	"HPA056293: AB_2683089, HPA072563: "	"unprognostic (1.52e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.05e-2)"	"unprognostic (3.56e-1)"	"unprognostic (1.41e-2)"	"unprognostic (4.49e-3)"	"unprognostic (2.61e-1)"	"unprognostic (1.10e-1)"	"unprognostic (9.05e-2)"	"unprognostic (2.99e-2)"	"unprognostic (3.08e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.24e-2)"	"unprognostic (5.10e-2)"	"unprognostic (2.29e-1)"	"unprognostic (5.06e-2)"	97.5	17.7	38.4	9.0	37.7	1.9	79.4	38.8	46.9	33.3	30.1	20.0	7.0	36.2	7.8	21.8	34.2	20.0	83.0	35.2	38.7	63.6	11.5	112.5	8.7	40.9	38.9	14.4	13.6	13.2	14.8	106.9	44.0	19.8	7.8	2.5	15.6	15.6	27.1	18.2	20.9	29.4	37.3	17.3	23.4	4.3	45.4	5.4	95.9	49.8	8.3	30.8	30.2	37.8	1.2	1.6	0.4	1.2	0.0	0.3	5.1	0.1	0.1	0.0	0.1	2.7	14.1	1.2	3.2	0.0	0.2	0.0	3.7	0.0	0.0	1.8	1.3	218.8	0.1	8.0	0.6	0.4	3.6	0.0	0.0	0.0	0.0	0.2	277.9	0.1	0.2	5.9	0.5	1.8	0.0	0.0	0.6	20.8	2.1	0.0	1.0	0.9	0.0	2.4	0.2	0.8	0.1	16.1	0.0	7.5	3.3	0.8	142.0	0.4	0.4	0.5	0.0	0.2	0.2	0.2	0.1	0.5	0.4	8.2	0.6	0.0	0.1	0.3	0.0	2.1	1.5	0.1	0.4	7.5	2.2	0.8	6.5	0.0	0.0	0.4	0.4	24.8	38.4	37.7	38.8	46.9	35.2	38.7	40.9	38.9	44.0	37.3	45.4	37.8	405.9	38.5	56.0	2.0	4.5	15.2	0.5	0.2	2.8	18.5	2.5	3.2	11.2	0.0	3.0	14.7	4.2	1.8	2.5	3.5	5.9	7.6	5.0	1.1	1.5	301.0	0.0	5.3	1.5	2.4	18.7	13.8	3.6	1.4	3.8	0.1	138.1	1.7	1.1	0.0	0.4	0.4	0.0	5.3	22.1	26.3	0.9	25.7	12.4	20.6	1.2	0.7	0.0	0.5	0.4	46.5	2.1	0.4	2.8	1.8	0.1	0.1	1.9	1.3	151.2	4.6	89.4	0.1	0.9	0.8	10.9	37.1	2.0	2.4	1.6	2.3
FLI1	"EWSR2, SIC-1"	ENSG00000151702	"Fli-1 proto-oncogene, ETS transcription factor"	Q01543	11	128686535-128813267	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 35.8"	"Cell type enhanced"	"Detected in many"		"B-cells: 65.7;Endothelial cells: 84.2;Hepatic stellate cells: 64.6;Kupffer cells: 86.4;Microglial cells: 231.4;monocytes: 68.4;NK-cells: 93.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 113.9;HUVEC TERT2: 60.5;REH: 49.8;TIME: 63.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065030, HPA073099"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		Yes	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Nuclear bodies"		"HPA065030: , HPA073099: AB_2686572"	"unprognostic (1.38e-2)"	"unprognostic (7.46e-2)"	"unprognostic (6.16e-2)"	"unprognostic (3.74e-2)"	"unprognostic (6.22e-2)"	"unprognostic (4.26e-3)"	"unprognostic (1.33e-1)"	"unprognostic (8.32e-3)"	"unprognostic (2.97e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (4.60e-4)"	"unprognostic (4.79e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.62e-1)"	"unprognostic (4.79e-2)"	10.2	1.9	3.7	10.9	2.3	12.2	6.0	2.1	2.8	5.7	1.2	3.7	3.2	4.6	1.1	2.8	2.7	6.1	6.2	1.8	2.9	2.1	2.8	10.8	12.3	4.7	2.7	1.2	1.7	3.5	0.7	12.5	4.3	1.9	2.9	0.5	2.2	2.2	2.8	1.7	4.0	5.9	3.5	35.8	4.3	0.9	3.9	17.2	2.9	6.6	10.4	6.7	1.9	2.8	0.2	0.0	5.6	0.0	0.8	1.0	0.1	3.3	9.2	3.8	3.1	0.0	0.0	18.5	31.7	11.1	1.1	0.1	0.8	13.5	4.1	9.0	0.2	113.9	0.5	0.0	6.0	13.7	14.6	0.8	1.1	7.7	17.3	11.1	60.5	25.6	0.0	23.3	0.8	0.0	13.3	8.1	1.8	0.0	3.1	49.8	0.1	19.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	5.0	0.0	20.4	63.0	0.7	0.0	0.2	3.5	7.3	16.4	16.6	0.1	31.8	5.2	34.5	15.5	24.5	10.1	15.3	11.9	6.8	8.9	8.2	19.1	6.0	3.7	8.2	11.8	12.3	19.1	3.3	11.1	20.1	3.7	2.3	2.1	2.8	1.8	2.9	4.7	2.7	4.3	3.5	3.9	2.8	53.4	6.4	5.3	0.3	65.7	5.1	0.3	1.7	2.2	0.0	0.7	1.3	5.5	5.7	0.1	1.8	0.0	0.4	43.1	0.0	0.0	0.0	0.5	0.4	0.6	84.2	0.0	23.4	0.3	0.0	0.4	5.9	2.0	0.3	22.8	0.0	64.6	1.3	43.2	0.0	1.5	0.1	0.0	86.4	24.7	0.5	1.8	60.3	7.2	231.4	68.4	0.1	93.7	4.0	0.7	0.0	0.0	0.7	56.9	0.3	0.0	0.4	0.8	0.4	6.6	2.1	3.1	0.2	0.1	0.6	4.1	0.3	52.8	0.9	0.2	0.4
ICAM2	CD102	ENSG00000108622	"Intercellular adhesion molecule 2"	P13598	17	64002594-64020634	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 168.1"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 341.8;Endothelial cells: 180.8;Hepatic stellate cells: 128.5;NK-cells: 106.1;Plasma cells: 114.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"HUVEC TERT2: 1260.8;TIME: 319.0"	"Low region specificity"	"Detected in all"							HPA071155			Approved	"Plasma membrane,Cytosol"		NA	NA		730000000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 16: Immune cells - Immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"	Cytosol	"HPA071155: "	"unprognostic (9.43e-3)"	"unprognostic (3.31e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.15e-1)"	"unprognostic (8.97e-2)"	"unprognostic (1.64e-3)"	"unprognostic (1.34e-1)"	"unprognostic (3.74e-1)"	"unprognostic (8.28e-2)"	"unprognostic (2.15e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.55e-2)"	"unprognostic (9.07e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.93e-2)"	"unprognostic (6.04e-2)"	"unprognostic (2.29e-1)"	97.4	11.3	39.6	30.4	39.6	20.7	78.7	40.3	48.3	20.3	34.6	26.3	14.1	24.4	6.7	12.1	22.2	18.8	99.7	38.2	40.5	44.3	14.6	84.5	60.5	42.1	40.9	12.7	15.4	9.0	12.4	79.3	42.9	16.1	18.2	1.2	16.0	8.6	37.9	16.3	34.2	29.5	41.4	168.1	18.8	3.5	44.6	31.5	33.6	55.9	41.8	33.0	21.4	40.6	0.0	0.0	0.0	0.0	11.3	10.8	3.2	1.1	0.7	0.3	1.1	2.7	52.2	92.9	16.6	0.0	0.3	0.4	1.2	0.0	1.7	22.3	0.0	82.9	4.4	10.0	1.8	14.2	0.3	0.4	0.0	0.8	0.2	0.0	1260.8	78.8	67.7	50.5	0.3	0.0	101.8	11.8	0.1	0.7	0.0	60.3	0.2	128.7	6.7	12.8	0.0	0.8	0.0	0.2	0.0	0.1	0.0	10.3	319.0	0.2	0.8	6.2	0.0	47.6	18.7	83.4	0.1	17.7	0.0	444.8	191.8	62.1	282.8	464.6	326.0	265.6	371.2	270.7	203.6	328.9	400.3	253.3	23.1	188.5	525.8	67.2	450.8	502.0	39.6	39.6	40.3	48.3	38.2	40.5	42.1	40.9	42.9	41.4	44.6	40.6	341.8	0.0	8.4	0.0	47.8	7.4	4.0	5.2	0.6	0.1	6.1	11.3	0.5	1.5	4.5	7.3	0.0	0.5	41.7	1.7	0.0	1.2	0.6	1.2	2.4	180.8	1.2	28.2	0.1	1.4	0.3	13.8	1.1	0.8	12.0	0.7	128.5	1.9	20.0	0.0	0.0	2.2	2.0	55.6	13.4	1.3	0.3	56.9	28.4	21.5	25.7	0.4	106.1	0.5	0.2	6.8	4.7	1.9	114.4	3.8	0.6	0.5	4.1	0.5	6.6	7.4	11.6	0.2	0.3	0.7	5.4	1.0	60.1	6.5	4.2	2.8
IL3RA	CD123	ENSG00000185291	"Interleukin 3 receptor subunit alpha"	P26951	X	1336616-1382689	"CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 79.0;dendritic cells: 137.5;Endothelial cells: 83.2;Langerhans cells: 47.6;monocytes: 72.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"basophil: 2665.0"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 2665.0"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 128.8;NB-4: 24.9;RPMI-8226: 54.1"									"HPA003539, CAB018374"	Uncertain					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"			"CAB018374: AB_2233620, HPA003539: AB_1078438"	"prognostic favorable (9.78e-4)"	"prognostic favorable (4.27e-4)"	"unprognostic (8.13e-2)"	"unprognostic (9.32e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.73e-2)"	"unprognostic (5.77e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.50e-3)"	"unprognostic (9.41e-2)"	"unprognostic (2.85e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.46e-1)"	25.2	2.9	7.1	15.8	13.6	25.0	20.6	16.1	11.7	6.4	0.2	8.1	5.5	8.7	1.6	5.4	8.0	11.3	13.0	5.9	8.1	9.2	1.8	25.0	25.1	11.7	10.6	8.8	5.4	3.4	2.8	6.2	11.1	7.0	6.6	22.0	9.5	3.2	12.1	12.7	9.2	12.3	7.5	11.1	6.9	3.5	10.1	4.4	10.3	8.6	13.0	12.4	6.3	20.5	0.2	9.4	3.6	1.3	0.1	0.0	1.1	1.2	0.3	0.0	0.1	0.9	1.5	1.2	7.2	0.2	0.6	9.6	0.0	0.0	0.0	128.8	3.9	0.6	2.1	0.4	0.0	0.8	15.6	0.0	0.0	0.0	0.0	4.1	8.2	0.9	0.3	6.1	0.0	1.4	0.7	24.9	3.1	0.8	0.5	1.4	4.2	54.1	0.0	1.4	0.6	0.4	0.6	0.3	2.8	1.8	1.2	17.8	0.4	0.5	1.5	0.5	0.3	12.5	3.9	1.1	9.8	2.8	0.1	2665.0	5.6	83.9	0.6	31.7	1.0	2.5	0.9	0.5	14.9	8.9	0.7	0.7	4.6	14.2	42.5	628.5	0.5	12.0	7.1	13.6	16.1	11.7	5.9	8.1	11.7	10.6	11.1	7.5	10.1	20.5	79.0	3.2	1.8	11.8	6.8	5.9	0.7	0.9	1.2	2.3	0.5	0.9	2.2	1.5	1.0	0.0	10.4	0.1	137.5	4.7	0.0	0.4	0.2	2.7	1.4	83.2	0.0	3.0	7.3	0.2	0.1	4.3	0.5	1.5	11.4	0.4	24.3	0.7	4.6	0.0	14.3	7.3	0.0	2.8	47.6	0.1	0.3	32.9	8.8	13.1	72.6	0.6	1.0	6.0	18.2	0.1	3.4	0.7	4.0	0.7	0.2	0.0	0.4	3.2	0.0	3.6	3.2	0.1	0.7	0.7	5.5	0.3	1.6	1.3	0.6	2.1
MMRN2	"EMILIN3, EndoGlyx-1, FLJ13465"	ENSG00000173269	"Multimerin 2"	Q9H8L6	10	86935540-86969481	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Angiogenesis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	11	"Adipocytes: 229.3;Endothelial cells: 127.1;Hepatic stellate cells: 182.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"CAPAN-2: 89.2;HUVEC TERT2: 196.6;TIME: 237.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020741			Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA		84000000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Vesicles		"HPA020741: AB_1848154"	"unprognostic (4.17e-1)"	"unprognostic (7.87e-2)"	"unprognostic (6.67e-3)"	"unprognostic (3.30e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.08e-2)"	"unprognostic (1.75e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.09e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.34e-1)"	"unprognostic (6.17e-3)"	"unprognostic (1.54e-3)"	"unprognostic (1.25e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.66e-1)"	63.2	13.9	14.0	10.1	12.7	1.5	54.5	11.5	12.5	20.6	11.0	14.2	10.5	28.1	13.8	16.9	22.7	16.6	38.8	11.4	11.9	22.0	8.6	32.1	9.7	13.6	12.4	23.1	10.5	10.6	7.6	73.8	13.7	14.1	8.9	3.0	26.6	28.7	26.8	38.9	13.8	27.3	13.2	34.6	11.9	15.3	15.8	6.5	25.8	32.5	13.3	32.3	19.1	12.0	11.4	2.9	0.4	0.2	1.2	6.3	7.1	4.1	11.1	4.8	6.8	6.4	89.2	0.1	39.5	7.6	11.6	21.9	0.0	5.2	6.4	8.1	0.0	2.3	10.2	0.2	0.9	0.0	4.6	1.5	26.4	5.7	38.6	13.0	196.6	2.4	2.1	35.0	1.8	7.1	0.4	4.4	2.0	0.4	4.9	0.2	0.1	0.1	2.0	17.5	4.8	0.0	3.1	3.7	1.4	0.9	14.9	1.2	237.1	1.9	11.0	1.9	0.1	2.6	4.0	0.1	5.8	0.1	2.5	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	14.0	12.7	11.5	12.5	11.4	11.9	13.6	12.4	13.7	13.2	15.8	12.0	229.3	0.0	5.8	1.6	0.3	9.4	0.9	0.0	4.6	0.2	1.4	2.0	13.2	5.7	0.7	1.8	0.0	0.7	0.4	0.0	0.0	0.1	1.0	0.3	0.4	127.1	0.0	2.7	0.9	0.0	0.1	8.1	0.0	0.5	0.0	0.2	182.0	4.1	1.7	0.0	1.2	0.0	0.0	6.5	4.4	2.8	2.5	0.7	3.6	15.9	0.0	0.7	0.0	1.0	0.1	0.0	0.0	3.0	0.1	0.6	0.5	0.2	0.0	0.6	6.6	3.9	9.4	1.8	2.3	2.2	7.7	0.3	0.8	3.6	0.2	1.0
PECAM1	CD31	ENSG00000261371	"Platelet and endothelial cell adhesion molecule 1"	P16284	17	64319415-64413776	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Phagocytosis"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 455.1"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 672.9;Endothelial cells: 468.2;Hepatic stellate cells: 275.3;Macrophages: 143.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"non-classical monocyte: 702.3"	"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"HUVEC TERT2: 773.0;TIME: 537.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004690, HPA004871"	Enhanced		Approved	"Nucleoli,Plasma membrane"		NA	NA		110000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"	Nucleoli	"HPA004690: AB_1078462, HPA004871: "	"unprognostic (2.79e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.79e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.34e-1)"	"unprognostic (4.42e-3)"	"unprognostic (2.84e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.57e-1)"	"unprognostic (7.25e-2)"	"unprognostic (4.53e-2)"	"unprognostic (9.68e-2)"	"prognostic unfavorable (8.98e-5)"	"unprognostic (9.72e-3)"	"unprognostic (9.57e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.16e-2)"	195.6	21.4	20.3	78.9	21.4	35.5	128.5	21.9	25.3	54.9	21.7	37.9	29.7	51.1	9.2	54.3	45.1	88.6	70.3	18.0	22.2	43.6	22.4	204.9	68.0	24.7	23.1	10.7	21.3	29.9	9.7	455.1	24.1	23.5	37.7	4.0	33.4	24.5	35.7	36.2	39.4	83.5	26.3	94.9	30.9	5.0	28.1	62.4	69.8	97.0	60.4	84.0	35.7	22.2	0.1	0.3	1.3	0.1	1.1	1.5	0.4	0.2	0.3	0.0	0.1	4.7	0.1	4.2	121.1	0.0	0.2	0.1	0.0	0.0	0.0	0.5	0.0	95.0	1.8	2.2	3.7	0.5	0.3	0.3	0.0	0.8	0.2	1.6	773.0	34.1	2.3	57.8	0.1	0.4	33.3	8.1	0.1	0.0	9.1	1.4	15.3	3.8	0.0	0.1	0.4	0.3	1.8	0.0	0.1	0.2	0.0	48.5	537.8	0.8	0.5	0.9	0.2	3.4	6.3	6.8	1.6	6.7	0.1	54.8	263.9	219.2	19.8	419.6	18.9	26.7	2.2	46.6	154.0	32.7	36.3	68.6	392.0	40.3	702.3	88.6	2.1	224.2	20.3	21.4	21.9	25.3	18.0	22.2	24.7	23.1	24.1	26.3	28.1	22.2	672.9	16.0	37.9	0.7	24.4	0.0	0.5	0.0	4.0	0.0	4.8	4.6	23.3	1.5	3.1	9.2	0.0	0.5	50.1	0.0	0.0	0.8	0.9	1.1	1.1	468.2	0.0	17.9	1.2	0.2	4.0	22.0	0.0	1.6	8.8	0.0	275.3	3.0	45.8	0.0	1.2	0.0	0.0	110.4	0.0	1.1	2.5	143.9	0.0	47.8	93.8	0.3	26.8	0.5	1.3	0.1	0.0	1.9	109.1	1.3	0.0	0.5	7.3	1.2	0.0	6.9	15.8	0.1	0.5	1.6	0.0	0.8	21.2	4.3	0.1	1.0
PTPRB	PTPB	ENSG00000127329	"Protein tyrosine phosphatase receptor type B"	P23467	12	70515870-70637440	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Angiogenesis	"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 215.9;Endothelial cells: 211.5;Hepatic stellate cells: 504.0;Microglial cells: 164.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"EFO-21: 24.3;hTERT-RPE1: 19.7;HUVEC TERT2: 61.4;TIME: 90.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004782, HPA067868"	Uncertain		Approved	"Vesicles,Plasma membrane,Cell Junctions"		NA	NA		14000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"	"Vesicles, Cell Junctions"	"CAB004782: , HPA067868: AB_2685911"	"unprognostic (3.18e-1)"	"unprognostic (2.99e-6)"	"unprognostic (1.56e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.77e-2)"	"prognostic favorable (6.05e-4)"	"unprognostic (4.59e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.40e-1)"	"prognostic favorable (1.02e-4)"	"unprognostic (2.91e-2)"	"unprognostic (7.18e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.38e-1)"	26.7	9.4	16.0	4.7	14.1	0.1	18.8	12.3	12.1	12.8	7.1	10.9	7.5	12.3	4.4	6.8	10.8	14.7	23.2	10.1	12.4	22.5	16.7	35.7	3.2	15.9	14.2	4.0	6.2	7.8	4.7	32.6	18.1	6.3	11.1	1.4	3.3	8.0	17.1	4.1	9.3	18.1	12.4	30.0	6.2	2.5	19.0	3.0	14.8	38.8	3.4	7.7	5.3	11.9	4.4	0.3	1.9	0.2	0.0	0.1	0.9	0.9	4.2	2.2	5.2	0.1	3.4	1.7	24.3	0.6	0.4	15.2	0.2	0.7	7.8	1.3	0.7	0.4	1.7	1.1	0.2	0.7	0.0	0.1	0.7	6.1	0.0	19.7	61.4	0.0	3.6	1.0	1.3	0.0	0.1	0.0	2.3	4.4	0.9	0.1	1.6	0.9	11.3	1.8	0.0	0.8	1.6	0.0	3.5	0.4	0.0	1.5	90.3	0.9	0.9	0.4	5.4	1.1	0.9	0.8	0.4	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	16.0	14.1	12.3	12.1	10.1	12.4	15.9	14.2	18.1	12.4	19.0	11.9	215.9	0.0	13.2	2.0	3.1	3.7	0.8	1.0	0.0	7.1	0.9	0.9	12.3	11.5	1.3	3.7	0.0	0.0	2.0	12.8	0.0	1.5	4.6	2.2	0.7	211.5	0.0	16.0	52.5	0.9	0.0	7.3	1.5	4.0	25.2	0.5	504.0	4.7	0.4	5.0	68.8	6.4	0.0	20.0	4.6	3.0	1.2	1.2	5.4	164.9	0.0	0.4	0.0	2.5	2.9	12.2	11.1	0.0	0.1	0.8	3.2	0.1	0.2	0.9	0.0	6.4	5.2	0.7	0.7	0.9	1.6	0.0	1.0	1.8	6.8	0.7
ROBO4	"ECSM4, FLJ20798, MRB"	ENSG00000154133	"Roundabout guidance receptor 4"	Q8WZ75	11	124883691-124898500	"Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins"	"Angiogenesis, Differentiation"	"Developmental protein, Receptor"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"Adipocytes: 181.5;Endothelial cells: 119.7;Hepatic stellate cells: 148.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"HUVEC TERT2: 247.6;TIME: 224.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065212			Approved	"Plasma membrane"		NA	NA		380000000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"		"HPA065212: AB_2685434"	"unprognostic (2.86e-1)"	"unprognostic (9.35e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.82e-2)"	"unprognostic (6.97e-2)"	"prognostic favorable (4.85e-4)"	"unprognostic (7.94e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.73e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.17e-2)"	"prognostic unfavorable (8.73e-4)"	"unprognostic (1.55e-1)"	"unprognostic (4.63e-1)"	"unprognostic (5.15e-2)"	41.4	7.2	11.4	6.6	9.6	0.2	31.8	9.0	9.4	10.0	5.8	6.5	2.9	10.9	2.1	5.5	10.3	9.7	25.8	7.9	9.2	18.5	5.3	34.8	7.8	11.3	10.7	4.1	4.3	4.7	4.6	28.6	11.2	7.0	1.7	0.2	4.1	4.6	13.9	6.9	7.3	9.9	9.5	43.5	6.3	1.4	13.2	1.8	16.7	11.9	2.0	9.4	7.0	8.6	0.4	0.0	0.4	0.0	0.0	1.1	0.1	0.2	3.1	0.7	1.5	0.0	0.0	0.0	23.6	0.1	1.0	0.0	0.0	0.4	1.2	0.0	0.0	0.9	0.0	0.1	0.6	0.0	0.0	0.1	0.0	8.9	3.0	0.4	247.6	0.0	0.0	0.0	8.6	0.0	0.0	0.2	0.0	0.0	3.4	0.0	8.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	224.8	1.2	0.6	0.3	1.1	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	9.6	9.0	9.4	7.9	9.2	11.3	10.7	11.2	9.5	13.2	8.6	181.5	0.0	4.2	2.3	1.6	2.2	1.0	0.2	0.6	0.2	0.6	1.0	3.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.5	0.5	0.2	0.3	119.7	0.0	4.0	0.0	0.2	0.0	5.2	0.0	0.3	2.5	0.6	148.9	1.5	0.1	0.0	0.0	0.0	0.0	8.1	3.7	1.7	4.4	2.8	1.8	20.6	0.1	1.1	0.0	0.5	0.1	0.1	0.0	1.2	2.6	0.3	0.0	0.0	0.0	5.2	0.0	4.5	2.1	0.0	0.1	0.6	1.3	0.0	0.9	2.0	0.1	0.2
S1PR1	"CD363, D1S3362, edg-1, EDG1"	ENSG00000170989	"Sphingosine-1-phosphate receptor 1"	P21453	1	101236865-101243713	"Cancer-related genes, CD markers, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Angiogenesis, Chemotaxis"	"G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 236.1;Endothelial cells: 122.3;Hepatic stellate cells: 114.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 1248.4"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ: 73.0;HUVEC TERT2: 198.9;TIME: 113.3;U-251 MG: 147.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010104, HPA075568"	Supported		Supported	Vesicles		No	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Vesicles		"CAB010104: AB_2238920, HPA075568: AB_2686758"	"unprognostic (1.41e-1)"	"unprognostic (9.35e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.61e-1)"	"unprognostic (9.78e-2)"	"unprognostic (4.49e-3)"	"unprognostic (1.34e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.36e-1)"	"unprognostic (9.12e-2)"	"unprognostic (2.34e-2)"	"unprognostic (2.23e-1)"	"unprognostic (5.82e-3)"	"unprognostic (2.54e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.64e-1)"	"prognostic unfavorable (8.78e-4)"	114.7	14.4	58.8	29.8	62.7	18.5	91.9	59.8	59.0	18.5	27.8	19.5	9.4	24.7	3.9	26.8	22.9	28.0	71.8	51.3	65.1	18.0	31.3	78.3	46.3	65.2	73.0	8.2	20.3	23.3	8.7	48.1	61.3	13.7	10.1	14.6	15.0	7.8	27.9	17.9	22.3	31.2	57.6	63.1	17.1	2.6	76.5	21.4	35.9	51.5	26.9	34.3	19.2	52.6	15.6	0.2	14.2	0.0	1.4	32.7	0.1	73.0	13.5	47.9	16.6	0.1	0.7	0.0	17.8	25.2	0.4	0.0	1.8	0.8	27.0	6.1	1.2	6.8	0.3	0.0	6.6	0.0	3.5	45.0	0.3	0.1	3.7	1.7	198.9	5.8	0.2	14.4	13.5	0.0	20.6	0.0	3.9	0.4	4.8	0.0	13.4	0.5	0.1	0.0	0.0	0.1	0.7	0.0	0.2	0.9	0.0	0.2	113.3	6.8	2.9	2.0	147.1	1.3	0.0	1.0	0.7	0.0	0.4	1248.4	2.2	55.4	589.4	2.1	441.5	294.7	502.6	492.1	2.6	346.9	383.3	396.3	15.4	397.5	3.4	3.1	329.4	438.7	58.8	62.7	59.8	59.0	51.3	65.1	65.2	73.0	61.3	57.6	76.5	52.6	236.1	0.0	8.9	37.9	36.0	7.6	0.2	0.0	2.2	0.4	1.1	1.1	23.8	2.8	1.3	0.0	0.0	5.9	25.0	0.0	0.0	0.0	0.0	1.1	1.0	122.3	0.0	0.4	0.1	0.0	0.3	11.7	0.5	1.8	7.6	9.7	114.2	8.9	9.9	0.0	0.3	0.0	0.0	6.5	5.7	0.0	0.9	3.0	5.4	13.1	9.9	31.1	40.2	0.5	0.2	0.0	0.0	0.0	18.2	0.5	0.0	0.1	0.0	1.4	0.0	3.6	4.8	0.7	0.7	0.6	5.1	2.6	29.9	1.8	0.1	0.4
TEK	"CD202b, TIE-2, TIE2, VMCM, VMCM1"	ENSG00000120156	"TEK receptor tyrosine kinase"	Q02763	9	27109141-27230174	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	Angiogenesis	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Glaucoma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 46.3"	"Group enriched"	"Detected in many"	10	"Adipocytes: 70.8;Endothelial cells: 73.9;Hepatic stellate cells: 122.0;Microglial cells: 38.4;Oligodendrocyte precursor cells: 137.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HUVEC TERT2: 90.9;NTERA-2: 45.2;TIME: 99.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010359, HPA073265"	Approved		Supported	"Plasma membrane,Centriolar satellite"	"Secreted to blood"	NA	NA	7750000	13000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"	"Centriolar satellite"	"CAB010359: AB_2203226, HPA073265: AB_2686592"	"unprognostic (2.24e-1)"	"unprognostic (1.74e-1)"	"unprognostic (5.55e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.26e-3)"	"prognostic favorable (2.31e-5)"	"unprognostic (7.48e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.58e-2)"	"unprognostic (2.72e-1)"	"prognostic favorable (7.81e-4)"	"unprognostic (7.50e-3)"	"unprognostic (6.87e-3)"	"unprognostic (1.83e-1)"	"unprognostic (5.24e-3)"	20.1	9.1	8.1	5.8	7.0	0.2	14.0	6.1	8.4	9.3	4.3	5.0	3.7	12.4	2.3	5.3	6.7	11.2	16.8	7.1	6.8	23.0	10.5	28.8	3.7	7.2	6.6	3.5	3.5	4.4	3.0	46.3	7.6	3.8	5.4	0.7	3.1	6.2	10.5	2.8	5.5	12.7	6.8	28.8	4.0	1.4	9.4	1.8	9.1	22.9	2.8	6.9	3.9	6.8	0.3	0.0	3.5	0.0	0.4	5.6	0.1	3.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	2.4	0.0	1.6	0.0	0.0	1.8	0.0	2.2	0.8	0.1	90.9	0.0	0.0	0.0	0.7	0.0	0.0	0.0	45.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	18.3	0.0	0.0	99.1	0.0	0.5	9.1	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	8.1	7.0	6.1	8.4	7.1	6.8	7.2	6.6	7.6	6.8	9.4	6.8	70.8	3.2	1.3	1.3	0.4	1.5	0.0	0.0	0.0	0.0	0.3	0.5	8.6	0.0	0.6	1.8	0.0	0.4	0.4	0.0	0.0	0.0	0.6	0.6	0.8	73.9	0.0	2.7	4.3	0.0	2.8	4.2	0.0	0.7	0.0	0.3	122.0	1.3	0.3	0.0	5.0	0.0	0.0	6.7	2.2	0.9	0.6	0.4	0.0	38.4	0.0	0.1	0.0	137.7	2.1	1.3	0.0	0.4	0.0	0.2	0.0	0.1	0.0	0.2	0.0	1.6	1.9	0.1	0.4	0.3	1.3	1.4	0.5	1.8	0.0	0.0
TIE1	"JTK14, TIE"	ENSG00000066056	"Tyrosine kinase with immunoglobulin like and EGF like domains 1"	P35590	1	43300982-43323108	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Angiogenesis	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Adipocytes: 130.8;Endothelial cells: 108.8;Hepatic stellate cells: 128.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	24	"basophil: 2.1;NK-cell: 2.5"	"Group enriched"	"Detected in many"	24	"granulocytes: 2.1;NK-cells: 2.5"	"Group enriched"	"Detected in some"	4	"EFO-21: 106.3;HUVEC TERT2: 238.4;TIME: 210.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"	NA	NA		87000000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"				"unprognostic (1.88e-1)"	"unprognostic (1.26e-1)"	"unprognostic (7.60e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.53e-3)"	"unprognostic (1.19e-2)"	"unprognostic (7.83e-2)"	"unprognostic (2.02e-1)"	"unprognostic (9.34e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.17e-3)"	"unprognostic (2.16e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.35e-2)"	47.0	10.1	16.6	8.1	14.8	0.9	37.8	14.6	16.9	14.0	10.1	11.2	5.2	20.4	5.3	6.5	16.0	13.3	34.2	13.1	14.2	19.8	6.7	35.3	10.1	16.4	16.5	7.5	4.2	3.2	8.0	48.6	16.8	10.8	3.1	0.4	7.4	6.5	14.0	7.9	11.0	14.1	13.9	19.9	8.8	3.0	21.1	2.1	24.2	20.7	2.9	15.1	11.8	14.8	0.0	0.0	3.6	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	106.3	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	41.9	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.2	0.0	1.7	238.4	0.0	0.0	0.0	0.0	0.0	0.0	20.4	1.3	0.0	0.1	8.1	16.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.9	0.0	0.1	210.0	1.2	0.4	0.0	0.2	0.0	0.2	0.4	0.0	0.0	3.9	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	16.6	14.8	14.6	16.9	13.1	14.2	16.4	16.5	16.8	13.9	21.1	14.8	130.8	0.0	4.2	0.0	0.4	2.2	0.6	0.0	1.2	0.3	1.0	0.9	4.9	1.5	1.8	0.0	0.0	0.3	0.7	0.9	0.0	0.0	2.0	0.1	0.4	108.8	0.0	2.5	0.4	0.2	0.1	3.1	0.0	0.4	20.3	0.1	128.8	1.3	0.5	0.0	0.2	0.1	0.0	5.6	3.1	2.5	2.1	1.1	1.8	29.0	0.1	0.1	1.0	1.0	1.1	0.0	0.0	0.7	0.1	0.7	0.1	0.9	3.6	0.9	0.0	2.2	2.2	0.9	0.7	0.5	1.4	0.3	2.3	0.5	0.2	0.7